ATLAS fair value
ATLAS has no fair value for this stock today.
Shandong Keyuan Pharmaceutical Co. Ltd. A stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - General · Shenzhen Stock Exchange · China
Prices as of Oct 27, 2026 · CNY
ATLAS has no fair value for this stock today.
48%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Shandong Keyuan Pharmaceutical Co. Ltd. A a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CN¥35.56 and CN¥43.02; in 9 out of 10, between CN¥30.03 and CN¥50.93. Estimated annual volatility is 54%.
ATLAS does not publish a fair value for 301281.SHE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 301281.SHE has traded between CN¥25.87 and CN¥59.24. Today it is 33.5% below that high and 52% above its low.
On the business: net margin is 7.7%; it trades at 116.1 times earnings.
Its beta is 0.19: it tends to move less than the market.
Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations.
Want to see everything about Shandong Keyuan Pharmaceutical Co. Ltd. A?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations.
48%: close to a coin flip. In half of the simulated outcomes, 301281.SHE ends the month between CN¥35.56 and CN¥43.02.
Shandong Keyuan Pharmaceutical Co. Ltd. A's market capitalization is CN¥4.4B. Its price-to-earnings (P/E) ratio is 116.1: you pay CN¥116.1 for each CN¥1.00 of yearly earnings.
Yes. 301281.SHE's current dividend yield is 0.12% at today's price (CN¥39.38).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy